Comparative Pharmacology
Head-to-head clinical analysis: CHG SCRUB versus PHISO SCRUB.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CHG SCRUB versus PHISO SCRUB.
CHG SCRUB vs PHISO-SCRUB
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Chlorhexidine gluconate disrupts bacterial cell membranes, leading to leakage of intracellular contents and cell death. It also binds to proteins and inhibits bacterial enzymes.
Phiso-Scrub is a topical antiseptic containing triclosan, which inhibits bacterial fatty acid synthesis by targeting enoyl-acyl carrier protein reductase (FabI), leading to disruption of cell membrane integrity and bacterial cell death.
Apply 5 mL to wet skin, scrub for 2 minutes, rinse thoroughly. Use undiluted.
Topical application to affected area once daily; chlorhexidine gluconate 4% scrub, lather for 3-5 minutes, rinse thoroughly.
None Documented
None Documented
Approximately 2 hours (terminal); prolonged in renal impairment.
Approximately 8-12 hours in patients with normal renal function (CrCl >90 mL/min). Half-life is significantly prolonged in renal impairment (up to 40 hours in ESRD).
Primarily renal (90% unchanged); <5% biliary/fecal.
Primarily renal excretion of unchanged drug (approximately 70-80% of absorbed dose). Biliary/fecal elimination accounts for the remainder (20-30%).
Category C
Category C
Antiseptic
Antiseptic